NCT01896544View on ClinicalTrials.gov

Cholecalciferol Supplementation for Sepsis in the ICU

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
Hypovitaminosis D
Interventions
DIETARY_SUPPLEMENT

Cholecalciferol

7ml syringe of cholecalciferol suspension given through nasogastric (NG) or orogastric (OG) tube

DIETARY_SUPPLEMENT

Placebo

7ml syringe of placebo cholecalciferol suspension given through nasogastric (NG) or orogastric (OG) tube

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01896544 - Cholecalciferol Supplementation for Sepsis in the ICU | Biotech Hunter | Biotech Hunter